Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001171843-26-002373

Chief Executive Officer acquired 2,578 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Nijhawan Pardeep Chief Executive Officer 2026-04-01 Grant or award +2,578 631,391 D: show line 1 in the form
Loading xslF345X06/ownership.xml…